Literature DB >> 15841464

Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town.

Gaspare Maria Pendino1, Andrea Mariano, Pasquale Surace, Carmelo Antonio Caserta, Maria Teresa Fiorillo, Angela Amante, Stefania Bruno, Carmelo Mangano, Irene Polito, Fulvia Amato, Rodolfo Cotichini, Tommaso Stroffolini, Alfonso Mele.   

Abstract

Serum biochemical liver tests (LTs) (ALT, AST, GGT) and platelet counts are often used to screen for chronic liver disease. Population-based data on abnormal LTs in Mediterranean areas are lacking. The prevalence and etiology of abnormal LTs were assessed from 2002 to 2003 in a 1 in 5 systematic random sample of the general population who were 12 years of age or older in Cittanova, a southern Italian town with 10,600 inhabitants. LTs, indices of metabolism, and markers of HBV and HCV infection were assayed and alcohol intake was recorded in the selected population. In virus-free individuals with abnormal LTs, LTs were retested, and upper abdominal echography and tests for other causes of liver damage were undertaken. Among the 1,645 individuals screened, the prevalence of anti-HCV was 6.5%; the prevalence was particularly high in individuals over 50 years of age. The corresponding prevalence for HBsAg was 0.8%. The overall prevalence of individuals with abnormal LTs was 12.7% (95% CI: 11.1-14.3). The probable cause of abnormal LTs was excessive alcohol in 45.6%, HCV in 18.6%, HBV in 1%, alcohol plus HCV and/or HBV in 8.8%, and rare diseases in 2%. In 24% of individuals with abnormal LTs, the probable cause was nonalcoholic fatty liver disease (NAFLD); in this subgroup, increased body weight, hypercholesterolemia, and hyperglycemia were common, and 63.3% of them had a bright liver at echography. In conclusion, in southern Italy, a Mediterranean area where dietary habits are different from those in industrialized areas, one eighth of the general population has abnormal LTs suggestive of possible liver damage; NAFLD appears to be emerging as a potentially important etiology of this presumed liver injury.

Entities:  

Mesh:

Year:  2005        PMID: 15841464     DOI: 10.1002/hep.20689

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  37 in total

1.  High seroprevalence of HCV in the Abruzzo Region, Italy: results on a large sample from opt-out pre-surgical screening.

Authors:  Ennio Polilli; Monica Tontodonati; Maria Elena Flacco; Tamara Ursini; Palmira Striani; Dante Di Giammartino; Maurizio Paoloni; Luigi Vallarola; Gabriella Lucidi Pressanti; Giorgia Fragassi; Patrizia Accorsi; Lamberto Manzoli; Giustino Parruti
Journal:  Infection       Date:  2015-09-12       Impact factor: 3.553

2.  Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival.

Authors:  Umberto Vespasiani-Gentilucci; Antonio De Vincentis; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

3.  How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.

Authors:  Varun Takyar; Anand Nath; Andrea Beri; Ahmed M Gharib; Yaron Rotman
Journal:  Hepatology       Date:  2017-07-27       Impact factor: 17.425

4.  Management of liver cirrhosis between primary care and specialists.

Authors:  Ignazio Grattagliano; Enzo Ubaldi; Leonilde Bonfrate; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

5.  Follow-up of mild alanine aminotransferase elevation identifies hidden hepatitis C in primary care.

Authors:  Charles Helsper; Gerrit van Essen; Bernard D Frijling; Niek J de Wit
Journal:  Br J Gen Pract       Date:  2012-03       Impact factor: 5.386

6.  After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.

Authors:  Mohamed El Kassas; Mohamed Alboraie; Aya Mostafa; Reem Ezzat; Adel El Tahan; Shimaa Afify; Ahmed Sweedy; Ibrahim Kabbash; Gamal Esmat
Journal:  J Clin Lab Anal       Date:  2017-07-28       Impact factor: 2.352

7.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

8.  Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest).

Authors:  Thierry Poynard; Pascal Lebray; Patrick Ingiliz; Anne Varaut; Brigitte Varsat; Yen Ngo; Pascal Norha; Mona Munteanu; Fabienne Drane; Djamila Messous; Françoise Imbert Bismut; Jean Pierre Carrau; Julien Massard; Vlad Ratziu; Jean Pierre Giordanella
Journal:  BMC Gastroenterol       Date:  2010-04-22       Impact factor: 3.067

9.  Longitudinal association of obesity, metabolic syndrome and diabetes with risk of elevated aminotransferase levels in a cohort of Mexican health workers.

Authors:  Yvonne N Flores; Allyn Auslander; Catherine M Crespi; Michael Rodriguez; Zuo-Feng Zhang; Francisco Durazo; Jorge Salmerón
Journal:  J Dig Dis       Date:  2016-05       Impact factor: 2.325

10.  Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patients.

Authors:  Klaus Langohr; Arantza Sanvisens; Daniel Fuster; Jordi Tor; Isabel Serra; Celestino Rey-Joly; Inmaculada Rivas; Roberto Muga
Journal:  Open AIDS J       Date:  2008-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.